AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Philosophy of Selling Directly to Consumers and the Limitations of FDA Approval
This chapter explores the speakers' decision not to seek FDA approval for a glucose control product, emphasizing the benefits of selling directly to consumers and democratizing its availability. They also discuss challenges with insurance coverage, limitations of diagnosis-based medication access, and provide information on Pendulum's website and special resources for healthcare practitioners.